Clinical Trial Update: A Phase II Study of KUC-7483 in Patients With Overactive Bladder [Phase 2]

View source ↗

Summary

Phase II study of KUC-7483 in overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• KUC-7483

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Overactive Bladder (OAB) | Phase 2 | Status: COMPLETED